Subcutaneous epcoritamab combined with R-CHOP for first-line treatment of patients with high-risk diffuse large b-cell lymphoma: phase 1/2 update
Lorenzo, F. Fritz, O. David, B. Joshua, B. Linton, Kim M Yasmin, K. Raul, C. Sylvia, S. Aqeel, A. Liwei, W.
Lorenzo, F.
Fritz, O.
David, B.
Joshua, B.
Linton, Kim M
Yasmin, K.
Raul, C.
Sylvia, S.
Aqeel, A.
Liwei, W.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Lorenzo F, Fritz O, David B, Joshua B, Linton KM, Yasmin K, et al. Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update. American journal of hematology. 2022 Oct;97:S30-S. PubMed PMID: WOS:000866743000050.